CME: Warfarin Use Up, but Fewer Brain Bleeds
SPONSORED BY
University of Pennsylvania School of Medicine Office of CME
MedPage Today
ACTIVE DATE
August 1, 2011 – August 1, 2012
CREDIT
Physicians: 0.25 AMA PRA Category 1 Credit(s)™
Family Physicians: 0.25 Elective credits
DESCRIPTION
Despite a nearly fourfold rise in the use of warfarin over a 15 year period, the occurrence of warfarin-related intracranial hemorrhage decreased by nearly the same rate, according to a Finnish population-based study.
LINK
for healthcare professionals
- Getting Started Home INR Monitoring
- Continuing Education
- CME: Chocolate Benefits Touted in Study
- CME: DVT Risk Starts Early, Stays Long After Stroke
- CME: Nationwide, Blacks Fare Worse Following Stroke
- CME: Older Afib Patients Tolerate Anticoagulants
- CME: Olive Oil Protects Against Stroke
- CME: Optimists May Have Fewer Strokes
- CME: The New Anticoagulants, a Stroke Prevention Clinical Context Report
- CME: Use of Warfarin in Afib Inconsistent
- CME: Warfarin Use Up, but Fewer Brain Bleeds
- CME: Stroke Risk in Afib Greater for Older Women
- CME: Cardiologists Urged to Lead in Smoking Cessation
- CME: New Tool Predicts Bleeding Tied to Warfarin Use
- Recent News
- WellLife Patient Education
